Joint “Rapid relative effectiveness assessment of new pharmaceuticals for the treatment of chronic Hepatitis C”

The purpose of the assessment is to evaluate multiple new pharmaceuticals for the treatment of Chronic Hepatitis C. Final version of the assessment was published in December 2015 Below is the documentation provided by the Joint Assessment authoring team: WP5-SA6 Final Appendix Feedback Complete 17122015WP5-SA6 Final Appendix Content Complete Update January 2016WP5-SA6 Final Version of […]